B. Coignard
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 0.1%
- SARS-CoV-2 and COVID-19 Research
- Clostridium difficile and Clostridium perfringens research
- COVID-19 Clinical Research Studies
- Infection Control in Healthcare
- Antifungal resistance and susceptibility
Papers in
-
- Infection Control in Healthcare 22
- Clostridium difficile and Clostridium perfringens research 12
- SARS-CoV-2 and COVID-19 Research 10
- Antimicrobial Resistance in Staphylococcus 7
- Antifungal resistance and susceptibility 4
-
- Antibiotic Use and Resistance 19
- Co-authors
- Ed J. Kuijper (2 shared papers)Peet Tüll (1 shared paper)Yann Le Strat (6 shared papers)Olivier Lortholary (3 shared papers)Françoise Dromer (3 shared papers)L. Clifford McDonald (1 shared paper)Preeta Krishnan Kutty (1 shared paper)Erik R. Dubberke (1 shared paper)
- Journals
- Eurosurveillance (22 papers)Infection Control and Hospital Epidemiology (7 papers)Clinical Microbiology and Infection (6 papers)Emerging infectious diseases (4 papers)Journal of Hospital Infection (4 papers)
- Partner nations
- FranceUnited KingdomGermany
In The Last Decade
B. Coignard
104 papers receiving 12.9k citations
B. Coignard's Hit Papers
Peers
Comparison fields: 5 of 176
- Applied Microbiology and Biotechnology 1.1k
- Infectious Diseases 6.6k
- Molecular Medicine 1.5k
- Modeling and Simulation 375
- Immunology 1.3k
Countries citing papers authored by B. Coignard
This map shows the geographic impact of B. Coignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Coignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Coignard more than expected).
Fields of papers citing papers by B. Coignard
This network shows the impact of papers produced by B. Coignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Coignard. The network helps show where B. Coignard may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Coignard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis Hit paper breakdown → | 2018 | 2405 |
| 2 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 3 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 1757 |
| 4 | Emergence of Clostridium difficile-associated disease in North America and Europe Hit paper breakdown → | 2006 | 746 |
| 5 | The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use Hit paper breakdown → | 2012 | 658 |
| 6 | Recommendations for Surveillance of Clostridium difficile–Associated Disease Hit paper breakdown → | 2007 | 504 |
| 7 | 2020 | 454 | |
| 8 | 2020 | 412 | |
| 9 | Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010 Hit paper breakdown → | 2014 | 343 |
| 10 | 2011 | 287 | |
| 11 | 2008 | 254 | |
| 12 | 2008 | 253 | |
| 13 | 2015 | 212 | |
| 14 | 2020 | 189 | |
| 15 | 2010 | 144 | |
| 16 | 2007 | 137 | |
| 17 | 2013 | 126 | |
| 18 | 2009 | 111 | |
| 19 | 2006 | 97 | |
| 20 | 2008 | 97 |
About B. Coignard
B. Coignard is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Medicine, Modeling and Simulation and Epidemiology, having authored 108 papers that have together received 13.2k indexed citations. Recurring topics across this work include Infection Control in Healthcare (22 papers), Antibiotic Use and Resistance (19 papers), Antibiotic Resistance in Bacteria (14 papers), Clostridium difficile and Clostridium perfringens research (12 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers), COVID-19 epidemiological studies (6 papers) and Antifungal resistance and susceptibility (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.1k citations), Infectious Diseases (6.6k citations), Molecular Medicine (1.5k citations), Modeling and Simulation (375 citations) and Immunology (1.3k citations). B. Coignard has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Ed J. Kuijper, Peet Tüll, Yann Le Strat, Olivier Lortholary, Françoise Dromer, L. Clifford McDonald, Preeta Krishnan Kutty, Erik R. Dubberke, Teresa C Horan and Xiaoyan Song. Their work appears in journals such as Eurosurveillance, Infection Control and Hospital Epidemiology, Clinical Microbiology and Infection, Emerging infectious diseases and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.